Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.
Journal: Cancer research
Published: August 21, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.
Journal: Science immunology
Published: August 15, 2025
Pancreatic Cancer's PD1-Roadblock: When T-Cell Reinvigoration Is Not Enough.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 18, 2023
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade.
Journal: Cancer discovery
Published: February 24, 2022
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.
Journal: Cancer immunology research
Published: November 05, 2021
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy.
Journal: The Journal of experimental medicine
Published: October 04, 2021
IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Journal: Gastroenterology
Published: August 02, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026